Novaliq's Series E Round

Novaliq raised a round of funding on April 11, 2013. Investors include dievini Hopp BioTech Holding & Co..

Novaliq is a drug delivery company whose goal is to develop pharmaceutical formulations. Its semifluorinated alkanes (SFAs) can be used in various routes of administration for the transport of drugs o…

Articles about Novaliq's Series E Round: